Dr. Sam Kuna led the PSG/CPAP Core Lab for the NIH funded CATNAP (CPAP Apnea Treatment North American Program) project, a 6-site clinical trial assessing the effect of CPAP treatment on functional outcomes in patients with milder OSA. Dr. Kuna is leader of a NIH program project grant project comparing the effect of CPAP treatment on intermediate cardiovascular risk factors in patients with OSA. He has authored over 60 peer reviewed original research articles.